STAAR Surgical (STAA) Competitors $17.85 +0.29 (+1.65%) Closing price 07/3/2025 01:23 PM EasternExtended Trading$17.86 +0.00 (+0.03%) As of 07/3/2025 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock STAA vs. ICUI, XRAY, QDEL, NEOG, CERS, OSUR, UTMD, ANIK, WST, and COOShould you be buying STAAR Surgical stock or one of its competitors? The main competitors of STAAR Surgical include ICU Medical (ICUI), DENTSPLY SIRONA (XRAY), QuidelOrtho (QDEL), Neogen (NEOG), Cerus (CERS), OraSure Technologies (OSUR), Utah Medical Products (UTMD), Anika Therapeutics (ANIK), West Pharmaceutical Services (WST), and Cooper Companies (COO). These companies are all part of the "health care supplies" industry. STAAR Surgical vs. Its Competitors ICU Medical DENTSPLY SIRONA QuidelOrtho Neogen Cerus OraSure Technologies Utah Medical Products Anika Therapeutics West Pharmaceutical Services Cooper Companies ICU Medical (NASDAQ:ICUI) and STAAR Surgical (NASDAQ:STAA) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, dividends, media sentiment, risk, institutional ownership, valuation, earnings and analyst recommendations. Do institutionals and insiders hold more shares of ICUI or STAA? 96.1% of ICU Medical shares are owned by institutional investors. Comparatively, 96.7% of STAAR Surgical shares are owned by institutional investors. 1.5% of ICU Medical shares are owned by company insiders. Comparatively, 1.0% of STAAR Surgical shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Do analysts recommend ICUI or STAA? ICU Medical presently has a consensus price target of $192.67, suggesting a potential upside of 42.19%. STAAR Surgical has a consensus price target of $24.63, suggesting a potential upside of 37.96%. Given ICU Medical's stronger consensus rating and higher probable upside, analysts plainly believe ICU Medical is more favorable than STAAR Surgical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score ICU Medical 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.00STAAR Surgical 1 Sell rating(s) 9 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Which has preferable earnings & valuation, ICUI or STAA? STAAR Surgical has lower revenue, but higher earnings than ICU Medical. ICU Medical is trading at a lower price-to-earnings ratio than STAAR Surgical, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioICU Medical$2.38B1.40-$117.69M-$3.83-35.38STAAR Surgical$313.90M2.82-$20.21M-$1.44-12.40 Does the media favor ICUI or STAA? In the previous week, STAAR Surgical had 2 more articles in the media than ICU Medical. MarketBeat recorded 4 mentions for STAAR Surgical and 2 mentions for ICU Medical. ICU Medical's average media sentiment score of 0.77 beat STAAR Surgical's score of 0.62 indicating that ICU Medical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment ICU Medical 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive STAAR Surgical 2 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is ICUI or STAA more profitable? ICU Medical has a net margin of -3.87% compared to STAAR Surgical's net margin of -25.46%. ICU Medical's return on equity of 6.75% beat STAAR Surgical's return on equity.Company Net Margins Return on Equity Return on Assets ICU Medical-3.87% 6.75% 3.20% STAAR Surgical -25.46%-10.59%-8.32% Which has more volatility & risk, ICUI or STAA? ICU Medical has a beta of 0.87, meaning that its stock price is 13% less volatile than the S&P 500. Comparatively, STAAR Surgical has a beta of 0.58, meaning that its stock price is 42% less volatile than the S&P 500. SummaryICU Medical beats STAAR Surgical on 11 of the 17 factors compared between the two stocks. Get STAAR Surgical News Delivered to You Automatically Sign up to receive the latest news and ratings for STAA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding STAA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart STAA vs. The Competition Export to ExcelMetricSTAAR SurgicalMED/DENTAL IndustryMedical SectorNASDAQ ExchangeMarket Cap$884.53M$15.70B$5.55B$9.04BDividend YieldN/A1.40%5.22%4.00%P/E Ratio-12.4019.9027.6420.24Price / Sales2.822.18417.15117.30Price / CashN/A17.3536.8958.10Price / Book2.213.838.035.67Net Income-$20.21M$430.42M$3.18B$249.21M7 Day Performance5.50%1.64%2.93%3.28%1 Month Performance-0.11%0.78%1.72%3.95%1 Year Performance-60.27%21.84%34.39%20.98% STAAR Surgical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)STAASTAAR Surgical4.0049 of 5 stars$17.85+1.7%$24.63+38.0%-60.3%$884.53M$313.90M-12.401,211ICUIICU Medical4.5255 of 5 stars$132.15+0.3%$192.67+45.8%+14.5%$3.24B$2.38B-34.5015,000Positive NewsXRAYDENTSPLY SIRONA4.4688 of 5 stars$15.88-0.3%$20.36+28.2%-32.7%$3.17B$3.79B-3.5014,000News CoveragePositive NewsAnalyst DowngradeQDELQuidelOrtho4.4935 of 5 stars$28.82-0.2%$44.33+53.8%-3.5%$1.95B$2.78B-5.806,600NEOGNeogen4.0069 of 5 stars$4.78+1.1%$7.50+56.9%-65.0%$1.03B$924.22M-2.142,110Analyst RevisionHigh Trading VolumeCERSCerus3.3627 of 5 stars$1.41-0.7%$3.50+148.2%-11.8%$271.45M$180.27M-14.10290News CoveragePositive NewsOSUROraSure Technologies1.0184 of 5 stars$3.00-0.3%$3.00-21.6%$225.15M$185.83M-7.14840UTMDUtah Medical Products1.8567 of 5 stars$56.92-1.5%N/A-11.4%$187.75M$40.90M15.06180News CoverageANIKAnika Therapeutics3.7653 of 5 stars$10.58-1.5%$20.00+89.0%-56.1%$154.03M$119.91M-2.73300News CoverageWSTWest Pharmaceutical Services4.7607 of 5 stars$218.800.0%$320.00+46.3%-31.3%$15.72B$2.89B34.3510,600COOCooper Companies3.4189 of 5 stars$71.16+0.0%$99.70+40.1%-15.0%$14.23B$3.90B34.5416,000 Related Companies and Tools Related Companies ICU Medical Competitors DENTSPLY SIRONA Competitors QuidelOrtho Competitors Neogen Competitors Cerus Competitors OraSure Technologies Competitors Utah Medical Products Competitors Anika Therapeutics Competitors West Pharmaceutical Services Competitors Cooper Companies Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:STAA) was last updated on 7/6/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThe day and month stocks are most likely to crash nextGood News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history giv...Chaikin Analytics | Sponsored140% Yields From Stocks Like Tesla? Here's How (July 4th Special)Imagine getting a 140% dividend from your investments. Even better? It works with big names like Tesla, ...Investors Alley | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump's ticking time bombA looming tariff deadline on July 9th could be the spark — but what’s buried inside a recent White House docum...Porter & Company | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding STAAR Surgical Company Please log in to your account or sign up in order to add this asset to your watchlist. Share STAAR Surgical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
